thiazoles has been researched along with Lymphoma, Non-Hodgkin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Han, X; Shen, Y; Shi, Y; Wang, J; Wang, S; Yao, J; Zhang, N | 1 |
| Baer, MR; Hassan, HE; Hedrich, WD; Heyward, S; Wang, H; Xiao, J; Zhang, J; Zhang, Y | 1 |
| Aboukameel, A; Azmi, AS; Baloglu, E; Bhutani, D; Carlson, R; Elloul, S; Kauffman, M; Mohammad, RM; Muqbil, I; Senapedis, W; Shacham, S; Zonder, J | 1 |
| Chowdhury, A; Chowdhury, S; Tsai, MY | 1 |
| Jin, F; Joshi, I; Obasaju, C; Smith, MR | 1 |
| Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
| Rozmysłowicz, T | 2 |
| Bryan, GT; Cohen, SM; Ertürk, E | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
1 trial(s) available for thiazoles and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
CRM1 as a new therapeutic target for non-Hodgkin lymphoma.
Topics: Acrylamides; Acrylates; Animals; Antineoplastic Agents; Caspases; Cell Cycle Checkpoints; Down-Regulation; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Karyopherins; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Proteolysis; Receptors, Cytoplasmic and Nuclear; Thiazoles; Triazoles; Xenograft Model Antitumor Assays | 2015 |
10 other study(ies) available for thiazoles and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Coculture Techniques; Constitutive Androstane Receptor; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Gene Expression Regulation, Neoplastic; Hepatocytes; Histones; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Oxidative Stress; Oximes; Phosphorylation; Prednisone; Rats; Receptors, Cytoplasmic and Nuclear; Thiazoles; Vincristine | 2016 |
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Everolimus; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Lymphoma, Non-Hodgkin; Mice, Inbred ICR; Mice, SCID; Oxadiazoles; Prednisone; Protein Kinase Inhibitors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Time Factors; TOR Serine-Threonine Kinases; Transcription Factor RelA; Triazoles; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2016 |
A novel Aurora kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in non-Hodgkin lymphoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Aurora Kinases; Biomarkers; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin B; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Histones; Humans; Lymphoma, Non-Hodgkin; Microtubule-Associated Proteins; Neoplasm Proteins; Nuclear Proteins; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Thiazoles; Transcription Factors; Xenopus laevis; Xenopus Proteins | 2012 |
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Combined Modality Therapy; Deoxycytidine; Gemcitabine; In Vitro Techniques; Inhibitory Concentration 50; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Neoplasm Transplantation; Poly(ADP-ribose) Polymerases; Rituximab; Tetrazolium Salts; Thiazoles; Translocation, Genetic | 2005 |
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
[Effect of thioproline in vitro on selected functions of peripheral blood lymphocytes from healthy persons and patients with lympho- proliferative syndromes].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; B-Lymphocytes; Blood Donors; Cyclic AMP; Cyclic GMP; Cytotoxicity, Immunologic; DNA; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Models, Biological; T-Lymphocytes; Thiazoles; Thiazolidines | 1991 |
Cytostatic influence of thioproline on peripheral lymphocytes of healthy persons and non-Hodgkin's lymphoma patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclic AMP; Cyclic GMP; Humans; In Vitro Techniques; Lymphocytes; Lymphoma, Non-Hodgkin; Reference Values; Thiazoles; Thiazolidines; Thymidine | 1989 |
Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adenofibroma; Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Female; Fibroma; Fibrosarcoma; Intestinal Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Rats; Salivary Gland Neoplasms; Skin Neoplasms; Splenic Neoplasms; Thiazoles; Time Factors; Transplantation, Homologous | 1970 |
Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position.
Topics: Adenocarcinoma; Adenofibroma; Animals; Body Weight; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Hydrazines; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Rats; Salivary Gland Neoplasms; Splenic Neoplasms; Thiazoles | 1970 |